Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?
Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?
Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?
Submitted by
admin
on February 5, 2022 - 12:04pm
Source:
Motley Fool
News Tags:
FDA
Merck
COVID-19
molnupiravir
Headline:
Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?
snippet:
Production plans call for 30 million courses by the end of the year.
But competition may take a bite out of an estimated $15 billion in sales.
Do Not Allow Advertisers to Use My Personal information
